Specifically in BC, increased expression of the CCT complex has been linked to enhanced in vitro growth/survival [65] and worse prognosis in patients [66] and specifically, elevated expression of TCP1 was associated with poor clinical outcomes in BC. This evidence concerns the gene FLVCR2 and breast cancer.